Neisseria meningitidis with decreased susceptibility to penicillin in Saskatchewan, Canada

Blondeau, Joseph M; Ashton, F. E.; Isaäcson, M; Yaschuck, Y; Anderson, Cheryl; Ducasse, G

doi:10.1128/jcm.33.7.1784-1786.1995

Cited by 30 publications

(2 citation statements)

References 19 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There seems to be an increasing number of reports of N. meningitidis strains with a reduced susceptibility to penicillin G in Canada (6,14,26). In the present study, 13 such strains were found, none of which produced beta-lactamase with the nitrocefin disk.…”

Section: Discussionmentioning

confidence: 99%

Meningococcal infections in the Province of Québec, Canada, during the period 1991 to 1992

et al. 1995

View full text Add to dashboard Cite

A total of 234 strains of Neisseria meningitidis obtained from hospitalized patients living in the province of Québec during the period 1991 to 1992 were characterized according to their serogroup, serotype, subtype, electrophoretic type, and antimicrobial susceptibility. All these strains were recovered from sterile body fluids, except for one strain that was isolated postmortem from a cutaneous lesion. For both years, serogroup C was the most prevalent (69.7%), followed by serogroup B (27.4%). Serotype 2a represented 80.3% of serogroup C isolates, and P1.2 was the most common subtype associated with this serotype. Clone ET 15 accounted for 76.5% of serogroup C isolates and 90.0% of serotype 2a strains. Although meningococcal disease occurred mostly in children under the age of 5 (9.7 cases per 100,000 children), with a peak incidence for children under 1 (20.3 cases per 100,000 children), most fatalities occurred among teenagers (12 to 19 years old). The total fatality rate was 11.5%, and serogroup C strains were responsible for 88.9% of these fatalities. Thirteen strains had a reduced susceptibility to penicillin G, and 28 strains were resistant to sulfadiazine. One strain was resistant to both rifampin and sulfadiazine and showed a reduced susceptibility to penicillin G.

show abstract

Section: Discussionmentioning

confidence: 99%

Meningococcal infections in the Province of Québec, Canada, during the period 1991 to 1992

et al. 1995

View full text Add to dashboard Cite

show abstract

“…In Belgium, serogroup B is the predominant sero‐group causing meningococcal disease, followed by serogroup C. No effective vaccine is currently available for protection against group B meningococcal disease, because the B capsular polysaccharide is not immunogenic in humans [4]. The recent emergence of penicillin‐resistant meningococcal strains [5,6] may create additional therapeutic problems.…”

Section: Distribution Of Serotypes and Subtypes Among 568 Serogroup Bmentioning

confidence: 99%